Integrated Regulation of Toll-like Receptor Responses by Notch and Interferon-γ Pathways
2008 · Immunity · 263 citations
https://doi.org/10.1016/j.immuni.2008.08.016
J
Julia Foldi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
168
Papers
1.9K
Citations
17
h-index
25
i10-index
Julia Foldi is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer, Hypoxia, and Metabolism & Cancer Genomics and Diagnostics. The author has an h-index of 17, co-authored 143 publications.
ORCID: 0000-0002-7504-867XPapers by this author
worksChanging frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers
2019 · The Lancet Oncology · 81 citations
https://doi.org/10.1016/s1470-2045(19)30158-5
Cytomegalovirus Infection after CD34+-Selected Hematopoietic Cell Transplantation
2016 · Biology of Blood and Marrow Transplantation · 31 citations
https://doi.org/10.1016/j.bbmt.2016.05.003
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers
2022 · npj Breast Cancer · 25 citations
https://doi.org/10.1038/s41523-022-00492-0
A precision medicine approach to metabolic therapy for breast cancer in mice
2022 · Communications Biology · 23 citations
https://doi.org/10.1038/s42003-022-03422-9
Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I–III HER2-positive breast cancer
2018 · Breast Cancer Research and Treatment · 18 citations
https://doi.org/10.1007/s10549-017-4653-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat